Guggenheim Securities is a company that provides Wilms Tumor Protein, Cancer immunotherapy, Immunotherapy and more. Guggenheim Securities is headquartered in United States New York. Guggenheim Securities was founded in 1999.
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of Guggenheim Securities
Sign up to view the full data
Free Trial Now
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by Guggenheim Securities
Sign up to view the full data
Free Trial Now
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for Guggenheim Securities
Sign up to view the full data
Free Trial Now
Download
Subsidiary Lists
Subsidiaries with patent applications for Guggenheim Securities
Sign up to view the full data
Free Trial Now
Download
Guggenheim Securities Frequently Asked Questions
What technical fields has Guggenheim Securities researched?
Guggenheim Securities has researched the technical fields related toWilms Tumor ProteinCancer immunotherapyImmunotherapyMonoclonal antibodyOncology drugs
What kind of company is Guggenheim Securities?
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners....
What is Guggenheim Securities's official website?
Guggenheim Securities's official website is https://www.guggenheimpartners.com/services/securities.aspx.